Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ADAM8 |
| Upstream (Parents) |
|---|
| (<<) ACTG1 → ADAM8 |
| (<<) ADCY6 → ADAM8 |
| (<<) ATIC → ADAM8 |
| (<<) CASP7 → ADAM8 |
| (<<) CISH → ADAM8 |
| (<<) DUSP10 → ADAM8 |
| (<<) FOXC2 → ADAM8 |
| (<<) GNA13 → ADAM8 |
| (<<) HS3ST2 → ADAM8 |
| (<<) IL1A → ADAM8 |
| (<<) KLF11 → ADAM8 |
| (<<) MYC → ADAM8 |
| (<<) NCOR1 → ADAM8 |
| (<<) PIK3R1 → ADAM8 |
| (<<) PLAUR → ADAM8 |
| (<<) RYK → ADAM8 |
| (<<) TFF1 → ADAM8 |
| (<<) TUBB2C → ADAM8 |
| Downstream (Children) |
|---|
| ADAM8 → CAV3 (>>) |
| ADAM8 → CLCA4 (>>) |
| ADAM8 → EGF (>>) |
| ADAM8 → INE1 (>>) |
| ADAM8 → SYNGR4 (>>) |
| ADAM8 → TP53 (>>) |
| ADAM8 → WNT3 (>>) |
